English
Pусский
Français
Deutsch
العربية
Português
Español
简体中文

Take A Look At Our Core Products

    First-class quality
    This area can be customized to add text, the length of the text is customized, does not affect the operation of the entire site.This area can be customized to add text, the length of the text is customized, does not affect the operation of the entire site.

    Focusing on In Vitro Diagnostics R&D and Manufacturing Since 1999

    Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. For over 20 years, we have been keeping developing and producing high quality products, from China’s first Specific Protein Analyzer to the most innovative nephelometer, GPP-100, from our renowned nephelometry kits (e.g. China’s best CRP, NGSP certified HbA1c, etc.) to all those never-compromised CLIA, biochemistry and HPLC reagents. With all products CE marked, our market presence currently spreads from across China to more than 60 countries including Italy, Romania, India, Switzerland, Turkey, Malaysia etc., Goldsite is expanding its footprint to become a global brand.
    24
    years

    Established

    500
    +
    Staff
    40000
    Factory Square
    100
    +
    Overseas Market

    International Advanced Reagent R&D And Production Center

    Goldsite Diagnostics Inc. brings together professionals with cutting-edge technology from home and abroad (more than 60% hold master's degree or above), introduces advanced testing technology from home and abroad, efficiently integrates global resources, has established several instrument R&D core project departments and reagent project R&D platforms, launched several instruments and reagent products, and has several forward-looking projects in the R&D stage. The company takes R&D innovation as the fundamental, and vigorously increases R&D investment to ensure the smooth implementation of scientific and technological projects.

    Certificate

    ​​​​​​​

    Applications Insights​​​​​​​

    /
    Inflammation | Pneumonia
    CRP
    /
    COVID-19
    SARS-CoV-2
    /
    Diabetes
    HbA1c
    /
    Thrombosis
    D-Dimer
    /
    Rheumatoid Arthritis
    Anti-CCP
    /
    Pregnancy
    /
    Thyroid

    News

    A Small, Dedicated Nephelometer for Measuring IgG, IgM, And Albumin

    Community Hospitals & Critical Access Hospitals (CAHs)Limited Lab Resources: These facilities often lack large, high-throughput automated analyzers due to space/budget constraints. A small nephelometer provides essential protein testing without a major capital investment.Moderate Test Volume: They h

    Goldsite Shines at MEDICA 2025: Innovative IVD Solutions Draw Global Attention

    November 21, 2025 (Düsseldorf, Germany) – The world’s most influential medical trade fair, MEDICA 2025, successfully concluded yesterday. Over the course of the four-day event, the Goldsite’s booth (Hall 1 / Booth 1B56) became a hub of activity, attracting professional visitors from over 60 countrie

    HbA1c Analyzer for 2025: Why the GSH-60 Revolutionizes Diabetes Testing and Thalassemia Screening

    In the fast-evolving world of diabetes diagnostics, finding the best HbA1c analyzer isn't just about speed—it's about precision, versatility, and real-world impact. As global diabetes cases surge toward 700 million by 2025, according to the International Diabetes Federation , healthcare providers ne

    Customer Distribution

    Contact Us For The Latest Quotation

    Get in touch

    Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

    Get in touch

        (+86)-755-26890807

            (+86)-755-26897973
       export@goldsite.com.cn

     

    Copyright © 1999- 2023 Goldsite Diagnostics Inc., All rights reserved.   Sitemap